► Please visit
"Questions & Answers #4" which generally addresses the
practice for Podiatrists Writing Prescriptions.
Notice to all Controlled Substances Registration
Registrants (Senate Bill 195 - 84th Session/2015).
[Posted 08/12/2016 @ 4:52
Senate Bill 195 (84th
Legislative Session; 2015),
eliminates the requirement for a
practitioner to have a Controlled Substances Registration with
the State of Texas, effective Sept.
1, 2016. As the provisions of
SB195 are implemented by the Texas State Board of Pharmacy
throughout the coming months, this webpage will be revised and
updated accordingly. Otherwise, SB195 has several key mandates:
bill transfers the Texas Prescription Program (and
the Ordering of Official Controlled Substances
Prescription Pads) to the Texas State Board of
Pharmacy from the Texas
Department of Public Safety.
eliminates the requirement for the Texas Department
of Public Safety - Texas Controlled
Substances Registration for those who
manufacture, distribute, prescribe, possess,
analyze, or dispense a controlled substance in this
state. Prescribers will only need to hold a
registration from the U.S. Drug Enforcement
The bill requires the Texas State Board of Pharmacy
to establish a Prescription Drug Monitoring Program
Database ("PMP AWARxE") for medical practitioners and state
regulatory agencies (and requires the Texas
Department of Public Safety to establish a separate
secure Prescription Drug Monitoring Portal for law
Please contact the Texas State Board of
Pharmacy to address any questions/requests related
to SB195 and the new Texas Prescription Program, to
include Ordering Official Controlled Substances
Prescription Pads and Registering for the
Prescription Drug Monitoring Program Database ("PMP
AWARxE"). Additional details follow below.
♦ Ordering Official Controlled Substances Prescription
Pads from the Texas State Board of Pharmacy. Again,
because the authority to issue prescription pads on/after
September 1, 2016 is being transferred to the Texas State Board
of Pharmacy, the Texas Department of Public Safety will not
issue prescription forms after September 1, 2016. To ensure the
orders received can be processed and the pads can be issued
prior to September 1, 2016 the Texas Department of Public Safety
will not process nor accept orders received after August 21,
2016. However, official prescription forms issued by the Texas
Department of Public Safety prior to September 1, 2016 will be
considered valid prescription forms. Official prescription pad
orders received after August 21, 2016 by the Texas Department of
Public Safety will be returned to the customer. On/after
September 1, 2016 all prescription pads must be ordered from the
Texas State Board of Pharmacy.
♦ Texas Department of Public Safety - Texas
Controlled Substances Registration Discontinued.
Effective September 1, 2016 prescribers will no longer need a
Controlled Substances Registration from the Texas Department of Public
Safety; prescribers will only need to hold a registration from
the U.S. Drug Enforcement Administration (DEA). Effective
September 1, 2016 the Texas Department of Public Safety will
discontinue accepting applications for the Texas Controlled
Substances Registration under §481.061 of the Texas Health &
Safety Code. Controlled Substances Registration applications
received on/after September 1, 2016 by the Texas Department of
Public Safety will be returned to the customer.
Registering for the New Prescription Drug Monitoring Program Database
("PMP AWARxE") at the Texas State Board of Pharmacy.
Effective September 1, 2016, the "Prescription Access in Texas"
(PAT) database hosted by the Texas Department of Public Safety
will be discontinued and the New Appriss' "PMP AWARxE" Prescription Drug
Monitoring Program Database hosted by the Texas State Board of Pharmacy
goes live. "PMP AWARxE" is a secure online
prescription monitoring program which will assist our Texas
health care prescribing professionals in quickly
identifying potential prescription drug abuse, patients who are
"doctor shopping" or forging prescriptions and prescribers who
are illicitly prescribing drugs.
"PMP AWARxE" provides
controlled substance prescription dispensing history to
authorized medical practitioners and licensing board investigators.
The Texas State Board of Pharmacy has created a
Short Video announcing the new
Prescription Drug Monitoring Program
As part of your Annual Texas Podiatry License Renewal Fee,
"Active - Status" Texas
Podiatrists will have already made the necessary payments to
Prescription Drug Monitoring Program
However, in order to obtain access, "Active - Status" Texas Podiatrists must
register with the Texas State Board of Pharmacy once the system
goes live on September 1, 2016.
The Texas State Board of Podiatric Medical Examiners
strongly encourages all "Active - Status" Texas Podiatrists to register for and
Texas State Board of Pharmacy's "PMP AWARxE"
Prescription Drug Monitoring
Program Database to combat all areas of prescription drug abuse. www.pharmacy.texas.gov/PMP/
Abuse/Misuse of Prescriptions/Pain
Medications & Drug Diversion Prevention (SB144-78th;
If you are a Podiatric Physician, please
click on the following link to learn more about
of Prescriptions/Pain Medications/Drug Diversion
accordance with the provisions of Senate Bill
144 (effective January 1, 2004; 78th Texas
Legislature). The informational site is
graciously hosted through the efforts of the
Texas State Board of Pharmacy.
For any other information regarding "Drug
Diversion/Drug Abuse," "Prescription Scope of
Practice Information," "Drug Rehabilitation," or
to "Report Incidents of Drug Diversion/Substance
Abuse/Physician Impairment," please contact Board
"Drug Diversion" is a nationwide problem
effecting physicians, patients and the general
public. Proper distribution and receipt of
"Controlled Substances" can not be achieved
without proper regulation. The Board can assist
anyone through open communication and reporting
of those matters posing a risk to the public
health, safety and welfare.
FDA News Release. For
Immediate Release: July 9, 2012:
introduces new safety measures for
extended-release and long-acting opioid
suspected "Prescription Fraud &
Drug Diversion", contact the
United States Drug Enforcement Administration (DEA)
- Office of Diversion Control
Prescribing Compounded Medications & Health Care Fraud.
Various providers prescribe compounded medications to treat
their patient's ailments; provided that
medical necessity, medical rationale and the standard of care
for its use are evident for best patient outcomes.
The U.S. Food & Drug Administration (FDA) has additional
"Compounding and the FDA: Questions and Answers" available
on their website.
Kickbacks: A health care provider or other
person engages in an illegal kickback scheme
when he or she offers, solicits, pays, or
accepts money, or something of value, in
exchange for the referral of a patient for
health care services that may be paid for by
Medicare or Medicaid. A laboratory owner and
doctor each violate the Anti-Kickback Statute
when the laboratory owner pays the doctor $50
for each Medicare patient a doctor sends to the
laboratory for testing. Although kickbacks are
often paid in cash based on a percentage of the
amount paid by Medicare or Medicaid for a
service, kickbacks may take other forms such as
jewelry, free paid vacations, or other valuable
"Questions & Answers #28"
from the Board's website which addresses
the overall nationwide problem of Health Care Fraud.
The patient's health and well-being must always take precedence
over the business
of medicine and the money that might be
made in treating patients. Prescribers usually do not benefit
monetarily when a prescription is written. The exception however
is if the prescriber owns (or is a partial owner or investor) of
a pharmacy or in some other way receives monetary value for
writing a prescription. Kickbacks are illegal. The patient must
be afforded the choice at which pharmacy to fill a prescription.
To report suspected "Medicare/Medicaid
Fraud, Waste & Abuse"
(to include "Federal Stark Law/False Claims Act/Anti-Kickback
Statute/Physician Self-Referral Law") call
toll free 1-800-HHS-TIPS (1-800-447-8477). This
service is a product of the
United States Department of Health & Human Services
- Office of Inspector General.
To report "Texas
Anti-Solicitation - Solicitation of Patients" complaints &
"Deceptive Trade Practices" complaints, contact the
Texas Attorney General's Office - Consumer Protection Division.
► Controlled Substances Schedule
♦ Hydrocodone - Schedule II.
[Posted 09/06/2014 @ 6:00 pm]
The Texas Department of
Public Safety (DPS) is informing Texans that hydrocodone
combination products (HCPs) have been moved from the
classification of a Schedule III drug to the more-restrictive
Schedule II drug, effective on Oct. 6, 2014. The U.S.
Drug Enforcement Administration’s rescheduling of HCPs as
Schedule II controlled substances will increase the restrictions
on prescribing and dispensing practices for hydrocodone
HCPs are drugs that contain both hydrocodone – which by itself is a
Schedule II drug – and specified amounts of other substances,
such as acetaminophen or aspirin. The federal Controlled
Substances Act places substances with accepted medical uses into
one of four schedules, with the substances with the highest
potential for harm and abuse being placed in Schedule II, and
substances with progressively less potential for harm and abuse
being placed in Schedules III through V. (Schedule I is
reserved for those controlled substances with no currently
accepted medical use and lack of accepted safety for use.)
HERE for additional information on the U.S. Drug Enforcement
HERE for the 09/05/2014 DPS Press Release.
HERE for the 08/21/2014 DEA Press Release.
HERE for a 09/12/2014 DPS
"Q&A Resulting from the Rescheduling of
[Posted 09/13/2014 @
Again, Hydrocodone Combination Products (HCPs) will be moving
from a Schedule III controlled substance to the more-restrictive
Schedule II, effective Oct. 6, 2014. The U.S. Drug Enforcement
Administration’s (DEA) rescheduling of HCPs as Schedule II will
increase restrictions on prescribing and dispensing practices
In preparation for the DEA rescheduling of HCPs, the Texas
Department of Public Safety (DPS) has increased staffing and
resources to respond to medical practitioners needing assistance
so they can better serve Texans who require prescriptions for
@ 8:36 pm]
Extended customer service availability from 7
a.m. to 7 p.m.
Implemented an automated call back system
allowing customers to make an appointment for an
agent’s return call.
Additional staff to help process registration
modifications to allow practitioners to change
their approved levels.
Extended work hours for staff in both the
Customer Contact Center
and Order Fulfillment areas.
Medical practitioners needing assistance can
either call (512)
424-7293 or send
a secured email.
Medical and mid-level practitioners will need to have correct
schedule designations on their registrations with DPS.
Practitioners need to use NAR-116 and
mid-level practitioners need to use NAR-117 to
Pad Mail-in Order Forms are
also on the DPS website.
For more information, please see Hydrocodone:
Schedule II Controlled Substance, DPS’
Press Release and DEA
Tramadol - Schedule IV.
09/06/2014 @ 6:00 pm]
DPS is also reminding
tramadol is now a Schedule IV controlled substance
as of Aug. 18, 2014.
For more information, visit http://www.justice.gov/dea/index.shtml.